A glimpse at Aeglea BioTherapeutics Inc.’s potential climb to old highs

The closing price of Aeglea BioTherapeutics Inc. (NASDAQ: AGLE) was $0.15 for the day, up 0.13% from the previous closing price of $0.15. In other words, the price has increased by $+0.0002 from its previous closing price. On the day, 518462 shares were traded. AGLE stock price reached its highest trading level at $0.1530 during the session, while it also had its lowest trading level at $0.1475.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



Our analysis of AGLE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.50 and its Current Ratio is at 3.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 25 when Souza Marcio bought 90,000 shares for $0.56 per share. The transaction valued at 50,472 led to the insider holds 90,000 shares of the business.

Hanley Jr. Michael Conick bought 28,200 shares of AGLE for $20,022 on Jun 08. The Chief Commercial Officer now owns 36,200 shares after completing the transaction at $0.71 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGLE now has a Market Capitalization of 9.74M and an Enterprise Value of -24.30M. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.23 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at -20.86 whereas that against EBITDA is 0.31.

Stock Price History:

Over the past 52 weeks, AGLE has reached a high of $1.64, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 0.2157, while the 200-Day Moving Average is calculated to be 0.4958.

Shares Statistics:

AGLE traded an average of 754.17K shares per day over the past three months and 373.64k shares per day over the past ten days. A total of 94.26M shares are outstanding, with a floating share count of 60.28M. Insiders hold about 0.20% of the company’s shares, while institutions hold 78.80% stake in the company. Shares short for AGLE as of Apr 27, 2023 were 429.9k with a Short Ratio of 0.43M, compared to 632.03k on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.66% and a Short% of Float of 0.67%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.15, while EPS last year was -$0.27. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.03 and low estimates of -$0.08.

Analysts are recommending an EPS of between -$0.36 and -$0.47 for the fiscal current year, implying an average EPS of -$0.41. EPS for the following year is -$0.09, with 2 analysts recommending between -$0.08 and -$0.11.